Crossref
COVID-19, Type 2 Diabetes, and Hypogonadism: Lessons for Acute Management and Long-Term Prevention
Androgens: Clinical Research and Therapeutics · 2020
DOI: 10.1089/andro.2020.0004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Androgens: Clinical Research and Therapeutics, 2020. Verfasst von Geoffrey Hackett und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 84 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hackett, G., & Kirby, M. (2020). COVID-19, Type 2 Diabetes, and Hypogonadism: Lessons for Acute Management and Long-Term Prevention. Androgens: Clinical Research and Therapeutics. https://doi.org/10.1089/andro.2020.0004
Vancouver
Hackett G, Kirby M. COVID-19, Type 2 Diabetes, and Hypogonadism: Lessons for Acute Management and Long-Term Prevention. Androgens: Clinical Research and Therapeutics. 2020. doi:10.1089/andro.2020.0004
BibTeX
@article{Hackett2020,
author = {Hackett, Geoffrey and Kirby, Michael},
title = {COVID-19, Type 2 Diabetes, and Hypogonadism: Lessons for Acute Management and Long-Term Prevention},
journal = {Androgens: Clinical Research and Therapeutics},
year = {2020},
doi = {10.1089/andro.2020.0004}
}
EUVIMED